Indeed, SIRT4 seems to have a tumor-suppressor role similar to that of SIRT3, as SIRT4-null mice develop lung tumors, loss of SIRT4 accelerates tumor progression in a mouse Burkitt lymphoma model and SIRT4 expression is reduced in several types of human cancers. Here, SIRT3 is linked to neoplasm.